It’s no secret, employee benefits are complicated. We’re here to break things down and help you build a roadmap for your approach to benefits. Together with our expert guests, we’ll explore complex, counterintuitive and compelling topics that give you a better understanding of the “whys” of the industry.

Specialty Drugs, GLP-1s, and the New Employer Pharmacy Reality

In this episode of Benefits Breakdown, the team is joined by Josh Halperin, Senior Vice President of Pharmacy Consulting Services at Brown & Brown. Together, they explore the rapidly changing pharmacy landscape—how the surge in specialty drug approvals, the rise of GLP-1 medications, and shifting oncology treatments are reshaping employer health plans. The conversation unpacks the financial impact of these trends, the promise of biosimilars, and the challenges posed by new legislation, direct-to-consumer pharmacy models, and drug import tariffs. 

Whether you’re a benefits leader, HR professional, or simply passionate about the future of pharmacy benefits, this episode delivers actionable insights and real-world strategies to help you navigate complexity, control costs, and plan for what’s next.

2025 PBM Industry and Market Update | October 2025 Edition

COVID-19 Vaccine Update: What Employers Should Know

This podcast is also available to stream on Spotify, Apple Podcasts, Amazon Music and more.

Vanessa Longnecker

Jared Bowcutt

Adam Compton